Peritoneal Dialysis Clinical Trials

11 recruiting

Peritoneal Dialysis Trials at a Glance

25 actively recruiting trials for peritoneal dialysis are listed on ClinicalTrialsFinder across 6 cities in 24 countries. The largest study group is Not Applicable with 10 trials, with the heaviest enrollment activity in Guangzhou, Hong Kong, and Chengdu. Lead sponsors running peritoneal dialysis studies include Chinese University of Hong Kong, Sichuan Academy of Medical Sciences, and Bodyport Inc..

Browse peritoneal dialysis trials by phase

Treatments under study

About Peritoneal Dialysis Clinical Trials

Looking for clinical trials for Peritoneal Dialysis? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Peritoneal Dialysis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Peritoneal Dialysis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 25 trials

Recruiting
Phase 3

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Peritoneal Dialysis Complication
University Health Network, Toronto20 enrolled1 locationNCT05715814
Recruiting

International (Pediatric) Peritoneal Biobank

HealthyKidney Failure, ChronicTransplantation+1 more
Heidelberg University500 enrolled26 locationsNCT01893710
Recruiting
Not Applicable

STarting incrEmental Prescription of Peritoneal Dialysis

Kidney FailurePeritoneal Dialysis (PD)
The University of Queensland224 enrolled6 locationsNCT06642597
Recruiting

Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)

Kidney DiseaseEnd Stage Kidney Disease (ESRD)Peritoneal Dialysis (PD)
Bodyport Inc.125 enrolled4 locationsNCT07059962
Recruiting
Phase 3

Comparing High and Low Dose Iron Treatments for People on Peritoneal Dialysis: The PALaDIN Study

Peritoneal DialysisAnaemia
Hull University Teaching Hospitals NHS Trust30 enrolled1 locationNCT06884280
Recruiting
Not Applicable

Effect of a Plant-Focused Diet on Nutritional Status in Malnourished Peritoneal Dialysis Patients

End Stage Kidney Disease (ESRD)End Stage Renal Disease (ESRD)Peritoneal Dialysis (PD)+1 more
National University of Malaysia100 enrolled1 locationNCT07157397
Recruiting
Not Applicable

Pilot Study to Evaluate the Feasibility, Adherence and Acceptance of the MiDiálisis Platform for Patients on PD

Peritoneal Dialysis (PD)
Aida Frías González55 enrolled1 locationNCT07326085
Recruiting
Phase 4

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

HypertensionPeritoneal DialysisEnd Stage Kidney Disease (ESRD)
Chinese University of Hong Kong40 enrolled1 locationNCT07271420
Recruiting
Not Applicable

Exploring Water-free Sodium Storage

Peritoneal Dialysis, Heart Failure
Yale University10 enrolled1 locationNCT06872645
Recruiting
Not Applicable

Efficacy and Safety of Nalfurafine Hydrochloride ODT for Moderate-to-Severe Pruritus in Patients on Peritoneal Dialysis

Peritoneal DialysisAdverse EventModerate-to-severe Pruritus+1 more
Guangdong Provincial People's Hospital93 enrolled1 locationNCT07098351
Recruiting
Not Applicable

Comparing Conventional Continuous Ambulatory Peritoneal Dialysis Prescription (C-CAPD) With Modified-CAPD (M-CAPD) Prescription in Children With End-stage Kidney Disease From Low-resource Settings

Children on Chronic Peritoneal Dialysis
National University Health System, Singapore44 enrolled1 locationNCT07134595
Recruiting
Phase 2

Empagliflozin on Residual Kidney Function in Incident Peritoneal Dialysis Patients

End Stage Renal Disease on DialysisPeritoneal Dialysis ComplicationResidual Kidney Function+1 more
Chinese University of Hong Kong48 enrolled1 locationNCT06483074
Recruiting
Not Applicable

Clinical Study of the Use of Amino Acid Peritoneal Dialysate in Diabetic Patients

DiabetesPeritoneal Dialysis
The People's Hospital of Gaozhou70 enrolled1 locationNCT07077538
Recruiting
Not Applicable

The Mobile-based Training System in Peritoneal Dialysis Patients

Peritoneal Dialysis
China Medical University Hospital50 enrolled1 locationNCT06876987
Recruiting
Phase 4

Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis

Vitamin D DeficiencyPeritoneal Dialysis-associated Peritonitis
Peking University First Hospital176 enrolled1 locationNCT05860270
Recruiting
Not Applicable

Dapagliflozin Delays the Loss of Renal Function in Peritoneal Dialysis Patients

Peritoneal Dialysis ComplicationSodium-glucose Co-transporter-2 InhibitorsRenal Function Aggravated
Sichuan Academy of Medical Sciences70 enrolled1 locationNCT06398977
Recruiting
Phase 4

Icodextrin Postpones the Shift of Low Dose to Full Dose Dialysis in the First Year of Incremental Peritoneal Dialysis

Peritoneal Dialysis
First Affiliated Hospital, Sun Yat-Sen University194 enrolled1 locationNCT05721404
Recruiting
Not Applicable

Exercise Improves Gastrointestinal Function in Peritoneal Dialysis Patients

ExerciseQuality of LifeChronic Kidney Diseases+2 more
Sichuan Academy of Medical Sciences132 enrolled1 locationNCT06368713
Recruiting
Phase 4

Clinical Trial on Antibiotic-Lock in Tenckhoff Catheter for Relasping and Repeat Peritonitis

Peritoneal Dialysis-associated Peritonitis
Alice Ho Miu Ling Nethersole Hospital46 enrolled1 locationNCT05971537
Recruiting

Determining the utility of uraemic toxins in peritoneal dialysis to optimise patient care

Peritoneal DialysisRenal Failure
Eastern Health Clinical School90 enrolled3 locationsACTRN12623000531617